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Abstract 
Our aim was to examine whether a new ratio, waist divided by height0.5 (WHT.5R), is both 
independent of stature and a stronger predictor of cardiometabolic risk (CMR) than other 
anthropometric indices.  
Subjects (4117 males and 646 females), aged 20-69 years, were assessed for stature (cm), mass (kg), 
waist and hip girths (cm) from which, body mass index (BMI), Waist to Hip ratio (WHR), Waist to 
Height ratio (WHTR) and two new indices, a body shape index (ABSI) and WHT.5R were determined. 
We used the allometric power law, W=a.HTb, to obtain a simple body-shape index for waist girth (W) 
to be independent of stature (HT). Physical activity was determined using self-report and physical 
fitness was determined using the Bruce protocol. Glucose, total cholesterol, low density lipoprotein, 
high density lipoprotein, triglycerides, and TC/HDL ratio were determined from fasting venous blood 
samples. A single CMR composite score was derived from log transformed z-scores of: Triglycerides + 
average blood pressure ((diastolic + systolic)/2) + glucose + HDL (*-1).   
Results confirmed WHT.5R to be independent of stature and the strongest predictor of CMR, 
compared to BMI, WC, WHR, ABSI and WHTR. We also found that CMR scores decline significantly 
with increasing fitness and physical activity, confirming that being fit and active can compensate for 
the adverse effects of being fat as measured by all other anthropometric indices.  
In conclusion, WHT.5R was the best anthropometric index associated with CMR, and being both 
physically fit and active has a protective effect on CMR, irrespective of weight status.  
Key words: Waist-to-Height0.5 Ratio; Allometric power law;; Waist-to-Height Ratio; Centralised 
Obesity 
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Introduction 
Although body mass index (BMI) remains a frequently used proxy for obesity, in recent years, 
measures of abdominal obesity, notably waist circumference (WC) and waist to height ratio (WHTR), 
have increasingly been linked with cardiometabolic risk in cross sectional and prospective studies 
(Ashwell, Gunn and Gibson, 2012). Meta-analytic (Lee et al., 2008) and systematic review data 
(Browning et al., 2010) has suggested that centralised measures of obesity are superior to body mass 
index (BMI) in detecting cardiometabolic risk (CMR). In the case of Browning et al (2010), both WC 
and WHTR were identified as superior to BMI as cardiometabolic risk predictors. More recently, 
Ashwell et al (2012) conducted a systematic review and meta-analysis with data representing over 
300,000 adults and concluded that WHTR was superior to both WC and BMI for detecting 
cardiometabolic risk in both males and females. They subsequently suggested that WHTR should be 
considered as a standardised screening tool for adult cardiometabolic risk. 
The mechanism as to why WHTR may be superior to other anthropometric measures in 
predicting cardiometabolic risk has been considered by previous authors. These proposed 
mechanisms largely relate to the higher metabolic and inflammatory activity of visceral fat depots 
within the abdominal cavity (Kuk et al., 2006) compared to subcutaneous adipose depots in other 
parts of the body (Manolopoulos et al., 2010). Such a suggestion is plausible in explaining why 
abdominal measures of obesity (WC), more reflective of visceral fat, are better than BMI for identifying 
cardiometabolic risk. However, there is less clarity as to why WC divided by height would be superior 
to WC alone in identifying cardiometabolic risk. Stature has been shown to have inverse associations 
with cardiometabolic morbidity and mortality (Langenberg et al., 2005). This is potentially because, in 
addition to a genetic component, stature can reflect early life exposures such as inadequate or 
malnutrition (Barker et al., 1990). Data from Chilean participants has also proposed that adverse 
environmental exposures in critical growth periods earlier in life ‘programme’ short stature and a 
predisposition to abdominal obesity and cardiometabolic risk factors in adult life (Koch et al., 2010). 
The authors suggest this offers a biologically plausible explanation as to why WHTR is superior than 
other anthropometric measures in explaining cardiometabolic risk in adults.  Despite this, there is still 
debate as to the utility of WHTR, over BMI or WC, in explaining cardiometabolic risk.  Moreover, WC 
is highly correlated with BMI making it difficult to separate the two as independent epidemiological risk 
4 
 
4 
 
factors (Moore, 2009). In an attempt to address this issue Krakauer and Krakauer (2012) developed a 
body shape index (ABSI, WC/(BMI2/3 _x height1/2)) based on WC that is independent of height and 
body mass and compared its ability to predict mortality risk in a sample of over 14000 adults 
alongside WC and BMI. They found that ABSI was not correlated with BMI and was a better predictor 
of mortality risk than WC or BMI and suggested that it would be beneficial to examine the utility of 
ABSI in predicting health risk in other data sets. Few studies to date appear to have acted on this 
suggestion. 
The aim of the current study was to explore whether recent assertions by Ashwell et al (2012) 
that the waist-to-height ratio is the strongest predictor of cardiometabolic risk in adults, or whether a 
new ratio, waist divided by height1/2 (WHT.5R), is both independent of stature and also a stronger 
predictor of CMR. We shall also attempt to extend the extant body of literature on this topic by 
providing an explanation as to why this new ratio (WHT.5R) may be superior to other anthropometric 
indices 
 
Methods 
 
Participants 
Following institutional ethics approval and informed consent, participants (n = 4763, 4117 males, 646 
females), aged 20-69 years (Mean age ± SD = 48.6 ± 8.2 years) attended one of five Health & 
Wellbeing clinics around England for a three-hour health assessment between 2000 and 2009. Prior 
to participation, participants were instructed in their  information pack to avoid any form of vigorous 
physical activity, alcohol and/or caffeinated beverages within the 24 hours prior to their assessment. 
Participants reported their sex, age, date of birth, and current home postcode. Date of birth was used 
to calculate age.  
 
Procedures 
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Anthropometry 
Body mass was measured using digital scales (Marsden, UK) and recorded to the nearest 0.1 kg. 
Clothing was worn but shoes and belts were removed, and participants evacuated their bladder 
before stepping onto the scales. Scales were calibrated daily with a known weight and bi-annually by 
the manufacturer. Stature was measured using a stadiometer (Seca, Hamburg, Germany) and 
recorded to the nearest 0.1 cm. Participants removed their shoes, stood on the platform with feet 
together, and head in the Frankfort plane. Buttocks and scapulae were in contact with the back of the 
stadiometer, shoulders relaxed with hands and arms loosely at the sides, the measurement was taken 
on full inhalation. WC was measured with participants standing with feet shoulder width apart using a 
standard, non-elastic anthropometric tape measure (Seca, Birmingham, UK). WC measures were 
taken end tidal to the nearest 0.1 cm, midway between the lowest rib and the iliac crest, which 
corresponded with the level of the umbilicus. Hip circumference was measured at the iliac crest (men) 
and by identifying the widest point of the pelvic region (women). Repeat measurements were made 
and the mean value of two measures which agreed to within 0.5 cm was used (WHO 1998). 
The anthropometric indices of weight status were calculated as follows: Body mass index 
(BMI) was calculated as weight (kg)/height2 (m2). WHR was calculated by dividing WC by HC, and 
WHTR, by dividing WC by height. A body shape index (ABSI) was calculated using formula: ABSI = 
WC/(BMI2/3 x height1/2) (see Krakauer and Krakauer, 2012). Finally, a new waist-to-height ratio 
(WHT.5R), independent of height, was calculated by dividing WC by height1/2 (for an explanation and 
justification, see statistical methods and results).  
 
Physical Activity 
The level of physical activity (PA) was self-reported by participants during a semi-structured interview. 
Each participant was asked to report their ‘normal’ frequency of moderate exercise sessions per week 
and was informed that moderate exercise was equivalent to brisk walking and that a bout of moderate 
exercise should be of at least 30 min duration. This was followed by self-report of strenuous 
(vigorous) activities using the same method as described above but where participants were told that 
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strenuous activity bouts needed to be 20-25 min and were given the examples of ‘going to the gym’ or 
participating in ‘sporting activities’. Responses were then categorised based on the recommended 
guidelines of 150 minutes of moderate activity and/or 75 min of vigorous activity per week (WHO, 
2010). 
 
Physical Fitness 
?̇?O2peak was used as a measure of physical fitness. Each participant was instructed in their pre-
assessment information pack to avoid any form of vigorous PA, alcohol and caffeinated beverages 
within the 24 hours prior to their assessment. After 5 min of rest in the supine position, a 12-lead 
electrocardiogram (ECG) (Marquette CASE, GE Healthcare, UK) was performed on all participants, 
which was reviewed by the duty medical officer.  
Participants walked on a treadmill (T2100, GE Healthcare Ltd., Buckinghamshire, UK) using 
the Bruce protocol (3 min incremental stages) (Bruce et al., 1972) and each was discouraged from 
holding the handrails. At the end of each minute, heart rate was monitored, and recorded every three 
minutes. Blood pressure was monitored at the second minute of each stage using the automatic 
Tango stress test BP monitor (Suntech Medical, Oxfordshire, UK). Rating of Perceived Exertion (RPE) 
was recorded at the end of each stage using the 6-20 Borg Scale (Borg, 1970), and ECG activity was 
monitored throughout the test. Participants exercised until volitional termination of the test or if they 
met any of the American College of Sports Medicine (ACSM) test termination criteria (ACSM, 2006). 
Peak oxygen uptake was estimated and reported in ml·kg-1·min-1. Data were divided into 10-year age 
strata and ?̇?O2peak (ml·kg-1·min-1) was classified as ‘Fit’ or ‘Unfit’ based on the Cooper Institute age- 
and sex-specific cut-offs (1994). 
 
Assessment of Cardiometabolic Risk 
In order to determine Cardiometabolic Risk, participants presented in a fasted state (defined as not 
having eaten for the previous 12 hours) At the start of each assessment. Fasting venous blood 
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samples were obtained using vacutainer tubes and heparinised whole blood was analysed using the 
Piccolo blood chemistry analyser (Abaxis, USA). The following CMR variables were measured: 
glucose, total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), 
triglycerides, and TC/HDL ratio. A single cardiometabolic composite score was then determined 
using: Triglycerides + average blood pressure ((diastolic + systolic)/2) + glucose + HDL (*-1). All 
variables are log transformed before the z-scores are formed and then summed and divided by 4. 
***Table 1 Here**** 
 
Statistical Methods 
We developed a simple body shape index for waist girth (W) to be independent of stature/height (Ht) 
using the allometric power law  
W=a.HTb.  (1) 
where a and b are the scaling constant and scaling exponents for the waist girth and  is the 
multiplicative error ratio (Nevill et al. 1992). Note that the multiplicative error ratio ‘’ assumes that the 
error will increase in proportion to body size (see Figure 1), a characteristic in data known as 
heteroscedasticity that can be controlled by taking logarithms, as described below.  Age and sex were 
incorporated into the model by allowing ‘a’ to vary for either sex and each age group (age categories 
20-29, 30-39, …, 60+) to accommodate the likelihood that waist girths may rise and then peak 
sometime during adulthood. The model can be linearized with a log-transformation, and multiple 
regression/ANCOVA can be used to estimate the stature/height exponent for waist girth having 
controlled for both age and sex. 
 
***Figure 1 Here*** 
 
To explored the strength of the association between cardiometabolic risk and the six anthropometric 
indicators of weight status (BMI, Waist circumference, Waist-to-hip ratio, Waist-to-height ratio, ABSI 
and Waist-to-height1/2), we conducted three types of analyses. The first (1), 6 MANOVA’s (using the 4 
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cardiometabolic risk factor variables as multivariate dependent variables) incorporating each 
anthropometric indicators of weight status as separate covariates, with all 6 analyses incorporating 
‘age group’ (age categories 20-29, 30-39, …, 60+) and ‘sex’ as fixed factors. The second set of 
analyses (2), used ANOVAs to explore the univariate cardiometabolic risk dependent variable, 
incorporating each of the six anthropometric indicators as separate covariates, again with ‘age group’ 
and ‘sex’ as fixed factors. Finally, the third set of analyses (3), adopted the same 6 ANCOVA 
analyses as in (2) but incorporated “meeting the PA guidelines” (entered as 0, 1 indicator variable), as 
well as ‘age group’ and ‘sex’ as fixed factors, plus ‘VO2peak’ as an additional covariate.  
To establish whether waist and hip girth measurements (G) increased in proportion to, or at a 
greater proportion to mass (M) assumed by geometric similarity, (i.e., M0.333), we adopted the same 
allometric model as above (see Nevill et al. 2004): 
G = a ·M b∙, (2) 
where a and b are the scaling constant and scaling exponents for the waist and hip girths and  is the 
multiplicative error ratio. Age and sex was incorporated into the model as described in (1). The model 
can be linearized with a log-transformation, and multiple regression/ANCOVA can be used to estimate 
the mass exponents for both waist and hip girths having controlled for both age and sex, also 
described in (1). 
  
Results 
The allometric power law model for waist girth (Eq 1), identified the height exponent to be 0.528 
(SEE=0.04) having controlled for both age and sex, suggesting that the simple body shape index for 
waist girth (W) to be independent of stature (HT) should be W.HT-0.5. 
The contributions of the six anthropometric covariates to the MANOVA analyses, having 
controlled for ‘age group’ and’ sex’ are given in Table 2. In all 6 MANOVA analyses, the main effects 
of ‘age group’, ‘sex’ and their interactions were significant (P<0.001). Note that the Wilks lambda 
ranges from 0 -1 and the lower the Wilks lambda, the greater the between-group variance or in our 
case, the stronger the relationship. This was confirmed by the larger F ratios. 
***Table 2 Here*** 
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The contributions of the six anthropometric covariates to the univariate ANOVAs of the 
Cardiometabolic risk-factor dependent variable are given in Table 3, having controlled for ‘age group’ 
and ‘sex’ 
***Table 3 Here*** 
 
When we incorporated the elements of fitness (VO2peak) and whether the participants met the 
physical activity guidelines into the analysis, the contributions of the six anthropometric covariates to 
the univariate ANOVAs of the Cardiometabolic risk-factor dependent variable, are given in Table 4, 
having controlled for ‘age group’ and ‘sex’ as before. 
***Table 4 Here *** 
 
To investigate whether the waist and hip girths were increasing/ expanding at a greater rate than that 
assumed by geometric similarity, the allometric models (2) were fitted to the data. The results suggest 
that both waist and hip girths are expanding at a greater rate than that anticipated by geometric 
similarity (M0.333), i.e., the fitted exponents were proportional to body mass, M0.610 and M 0.386 
respectively, having controlled for both age and sex. Note that the mass exponent SEE’s were 0.006 
and 0.003 respectively. As anticipated, the level of adiposity as measured by the waist when 
calculating the waist-to-hip ratio will be partially explained and hence diluted, rendering the ratio less 
effective at identifying the adiposity of overweight participants. 
The ROC analysis (Figure 2, area under the curve = 0.745 [95% CI 0.726 to 0.763]) identified 
the WHT.5R cut-off point to be 0.726 (Sensitivity=0.589 and Specificity=0.761) that would best 
discriminate between participants whose cardiometabolic score was greater than 1 standard deviation 
above the mean (Sardinha et al., 2016). For example, a 1.83m (6’ 0”) male’s waist should not exceed 
0.982m (38.7in). Similarly, a 1.70m (5’ 7”) female’s waist should not exceed 0.946m (37.2in).  
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***Figure 2 Here*** 
 
Discussion 
Our initial findings suggest that, based on the allometric power law (1), in order to obtain a waist girth 
index that is independent of stature, we need to calculate the ratio WHT.5R= Waist/Height1/2 rather 
than the more commonly used WHTR. 
Subsequently, we identified the strongest predictor of, or association with, cardiometabolic 
risk was indeed the waist-to-height1/2 ratio, identified in all three analyses (see Tables 2, 3 and 4). 
Indeed, the strongest through to the weakest anthropometric covariate associated with 
cardiometabolic risk was found to be the following order, (1) the waist-to-height1/2 ratio, (2) waist-to-
height ratio, (3) absolute Waist, (4) BMI, (5) waist-to-hip ratio, and finally (6) ABSI, an order that 
remained consistent in all three types of analyses, see Tables 2, 3 and 4. The second and third best 
predictors of cardiometabolic risk were waist-to-height ratio and absolute waist, certainly better than 
either BMI, waist-to-hip ratio, or ABSI.  These results lend some support to the assertions made by 
Ashwell et al. (2012) based on systematic review and meta-analysis that WHTR was more strongly 
associated with cardiometabolic risk than WC or BMI. The explanation as to why this might be the 
case is debated in the literature (See Kuk et al., 2006; Manolopoulos et al., 2010; Langenberg et al., 
2005). However, the present study offers, as far as we are aware, a novel anthropometric index 
(WHT.5R) that is not only independent of body stature but also consistently predicts cardiometabolic 
risk with the greatest precision. We offer the following viable and biologically plausible explanations 
for this consistent rank order in anthropometric indices, with WHT.5R rather than WHTR being the 
best index when predicting cardiometabolic risk.  
Any change in waist girth is likely to reflect changes in adiposity associated with 
cardiometabolic risk, whereas it is possible that changes in BMI might also reflect changes in muscle 
mass as well as adiposity, especially in younger (see Nevill and Metsios, 2015) and more athletic 
populations (see Nevill et al. 2006). This confirms that central adiposity is more relevant to 
cardiometabolic risk than being generally overweight as measured by stature-adjusted body mass, 
i.e., BMI.  
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The fact than absolute waist was not optimal when predicting cardiometabolic risk highlights 
the need for the waist girth measurements to be normalized for differences in body size (to be 
independent of body size), and hence to better reflect the centralized adiposity associated with 
cardiometabolic risk. However, in the past, the WHR has been thought to do precisely that, i.e., to 
“normalize” waist girth for individuals of different body size. So why does the waist-to-hip ratio come 
almost last of our competing anthropometric indices when predicting cardiometabolic risk? 
The explanation relies on the fact that not only does waist girths increase/expand in bigger subjects 
(M0.61) at a greater rate than that expected by geometric similarity (M0.333), hip girths also expands at a 
greater rate (M0.386) than that assumed by geometric similarity. As such, the level of adiposity as 
measured by the waist will be partially explained and hence diluted when the waist-to-hip ratio is 
calculated, a dilution that would be absent by dividing/normalizing by a body-size dimension such as 
stature/height that is unaffected by changes in adiposity. However, even the WHTR fails to normalise 
waist girth entirely. The only waist ratio that is entirely independent of body size (height) and elements 
of adiposity (e.g., hip girth and BMI) is WHT.5R, that might explain by WHR and ABSI are ranked 5th 
and 6th in our list of anthropometric indices predicting cardiometabolic risk, and why WHT.5R is 
ranked 1st. Note that the ratio ABSI divides waist by BMI2/3 and height1/2, the latter term providing 
some consistency with WHT.5R. 
We also found evidence of the so called ‘fat and fit’ phenomenon, i.e., in Table 4 we 
demonstrate that the cardiometabolic score declines significantly with increasing PA and fitness 
(VO2peak) but increases significantly with all measures of adiposity, e.g., WHT.5R, confirming the 
compensatory nature of being both fat and being fit (and active), that might result in a similar level of 
cardiometabolic risk to a more lean but less fit person. Previous research has shown that obese 
individuals with high levels of cardiorespiratory fitness have a lower risk of all-cause mortality and 
cardiovascular disease compared to lean individuals with low levels of cardiorespiratory fitness (Barry 
et al., 2014; Lee et al., 1999). Furthermore, overweight/obese individuals with higher cardiorespiratory 
fitness have reduced visceral adiposity and in turn a more favourable cardiometabolic risk profile (e.g. 
improvements in HDL-Cholesterol, triglycerides, blood pressure, and insulin resistance) compared to 
BMI-matched overweight/obese individuals with low cardiorespiratory fitness (Donovan et al., 2011; 
Arsenault et al., 2009; Rheaume et al., 2009). Our data were suggestive that with higher levels of 
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cardiorespiratory fitness even with greater adiposity (i.e. higher BMI, WC, WHR, WHTR, ABSI and 
WHT.5R) is associated with lower cardiometabolic risk profiles compared to those with the same level 
of adiposity but lower levels of cardiorespiratory fitness. We also found similar associations between 
higher levels of physical activity and adiposity and lower cardiometabolic risk, which is in line with the 
findings of previous studies (Jefferis et al., 2016; Kim et al., 2013).  
The current study is not without limitations and addressing these would provide key future 
research direction. Central adiposity can differ between individuals from different ethnic backgrounds 
and this may influence the applicability of WHT.5R across different ethnic groups. A natural 
progression from the work presented here, given the relatively fit and lean sample we examined, 
would be to examine the utility of WHT.5R as an anthropometric index associated with 
cardiometabolic risk in different groups including those of different ethnicity, those who are obese and 
across the adult lifespan. The anthropometric assessment was also completed with participants 
wearing light clothing (t-shirt and shorts). This may have contributed to some extra error in any index 
which used body mass. However, given the nature of the clothing worn any such error is likely to be 
minimal. 
Taken collectively, the results of the present study suggest WHT.5R may be a more useful 
anthropometric index associated with cardiometabolic risk compared to either WHTR, BMI, WHR, 
ABSI or WC alone and that cardiorespiratory fitness has a protective effect for cardiometabolic risk, 
even in those who are overweight and obese. For health practitioners and public health professionals 
the promotion of cardiorespiratory fitness should be a key message in reduction of cardiometabolic 
risk and the use of WHT.5R as a diagnostic screening tool should be encouraged over other 
measures of weight status including WHTR itself.  
 
 
Perspectives 
Recent research by Ashwell et al (2012) suggests that the waist-to-height ratio is the 
strongest predictor of cardiometabolic risk (CMR) in adults. Here we show that a new ratio, waist 
divided by height0.5 (WHT.5R), is not only independent of stature (using allometry) but also a stronger 
predictor of CMR compared with a wide range of other anthropometric indices including BMI, waist-to-
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hip ratio (WHR), waist-to-height ratio (WHTR), and a new body shape index (ABSI, WC/(BMI2/3 x 
height1/2)) Krakauer and Krakauer (2012).  
The likely explanations are twofold; (1) waist girth is the most sensitive dimension to detect changes 
in adiposity, certainly better than BMI that might reflect changes in muscle mass as well as adiposity, 
and (2) using height1/2 to normalize or scale waist girth for individuals of different body size is more 
suitable, since WHT.5R will be independent of stature but also height0.5 is unaffected by changes in 
adiposity, unlike hip girth and BMI, used to normalise WHR and ABSI respectively. We also found that 
CMR scores decline significantly with increasing fitness (VO2peak) and physical activity, confirming 
that being fit and active can compensate for the adverse effects of being fat as measured by all of the 
anthropometric indices.  
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Legend to Figures 
 
Figure 1 The relationship between waist circumference (cm) and stature (cm) for male and female 
subjects that demonstrates a multiplicative error ratio where the error increase in proportion to body 
size, a characteristic in data known as heteroscedasticity..  
 
Figure 2. The ROC analysis (area under the curve = 0.745 [95% CI 0.726 to 0.763]) identified the 
WHT.5R cut-off point to be 0.726 (Sensitivity=0.589 and Specificity=0.761) that would best 
discriminate between participants whose cardiometabolic score was greater than 1 standard deviation 
above the mean. 
 
1 
 
1 
 
 
 
 
Figure 2. The ROC analysis (area under the curve = 0.745 [95% CI 0.726 to 0.763]) identified the 
WHT.5R cut-off point to be 0.726 as indicated by the arrow  (Sensitivity=0.589 and 
Specificity=0.761) that would best discriminate between participants whose cardiometabolic score 
was greater than 1 standard deviation above the mean.   
 
Table 1. Descriptive summary data (Mean ± SD) for age, stature, body mass, waist, hip 
circumferences and cardiometabolic z-score by sex. 
 
 
Male N=4117 Female N=646 
 Mean SD Mean SD 
Age (yr) 48.87 8.195 46.89 8.752 
Stature (cm) 178.58 6.640 165.19 5.893 
Body mass (kg) 86.06 12.287 64.85 9.497 
BMI (kg.m-2) 26.96 3.345 23.76 3.254 
Waist (cm) 93.59 9.657 78.16 9.555 
Hip (cm) 103.44 6.407 98.72 6.827 
Cardiometabolic score .1027 .58192 -.6539 .51457 
 
Table 2. The contributions for the six anthropometric covariates to the cardiometabolic multivariate 
ANOVA (using Triglycerides, mean of Systolic and diastolic blood pressure, Glucose, High Density 
Lipoproteins, as the dependent variables) having controlled for ‘age group’ and ‘sex’. 
Anthropometric 
variable Wilks' Lambda F4,4705 
BMI 0.827 246.67 
Waist 0.822 255.22 
WHR 0.848 210.75 
WHTR 0.819 259.14 
ABSI 0.963 44.96 
WHT.5R 0.815 267.36 
 
Table 3. The contributions (slope parameters  (SEE), R2, R2adj, F ratios) of the six anthropometric 
covariates to the univariate ANCOVAs of the Cardiometabolic risk factor dependent variable, having 
controlled for ‘age group’ and ‘sex’. 
Anthropometric 
variable Anthropometric  R2 R2adj F1,4706 
BMI 0.071 (0.002) 0.322 0.321 965.08 
Waist 0.025 (0.001) 0.327 0.326 1004.17 
WHR 3.84 (0.13) 0.308 0.306 845.33 
WHTR 4.44 (0.14) 0.329 0.327 1017.75 
ABSI 24.99 (1.96) 0.211 0.209 163.05 
WHT.5R 3.44 (0.11) 0.333 0.331 1051.46 
Log-transformed High Density Lipoprotein z-scores were multiplied by -1 
 
